CPB Ljubljana 2018 course book

HDR BOOST with EBRT

• Optimal means of dose escalation for intermediate/high risk patients • Dose escalation results in better PSA RFS

• Acute toxicity equivalent or less than EBRT • Acute GU toxicity less than EBRT + LDR BT • Late toxicity equivalent to EBRT